Product Information

VIVELLE-DOT 0.0375 MG PATCH is a brand product labeled by Sandoz Inc., priced at $18.3766 per EA under NDC 66758014683. Its NADAC has been published 105 times since Nov 20, 2024.

FDA first approved this application on Jan 8, 1999. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VIVELLE-DOT 0.0375 MG PATCH

estradiol
$18.3766per EA

Strength

.0375 mg/d

Manufacturer

Sandoz Inc.

NDC

66758014683

Classification

Brand

Dosage Form

PATCH, EXTENDED RELEASE

Route

TRANSDERMAL

Effective Date

11/18/2026

Active Ingredients

ESTRADIOL

Approval Type

New Drug (NDA)

FDA Application

NDA020538

FDA Approved

1/8/1999

TE Code

AB1

On Market Since

1/8/1999

Pharmacological Classes

Estradiol Congeners
Estrogen Receptor Agonists
Estrogen

Price Statistics

The NADAC for VIVELLE-DOT 0.0375 MG PATCH has been published 105 times since Nov 20, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$18.3766 per EA
All-time high$18.5252 (Dec 11, 2024)
All-time low$18.3698 (Jan 21, 2026)
52-week high$18.3873
52-week low$18.3698
Median price$18.3806
Average price$18.3893
Largest weekly change-0.5% (Dec 18, 2024)
Weeks tracked105
Tracking sinceNov 20, 2024

Price History

1W

-0.0%

1M

+0.0%

3M

+0.0%

6M

-0.0%

1Y

-0.1%

3Y

N/A

5Y

N/A

All

-0.8%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 56% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of VIVELLE-DOT 0.0375 MG PATCH?

The current National Average Drug Acquisition Cost (NADAC) for VIVELLE-DOT 0.0375 MG PATCH, manufactured by Sandoz Inc., is $18.3766 per EA (NDC 66758014683), effective Nov 18, 2026.

How has the price of VIVELLE-DOT 0.0375 MG PATCH changed over time?

Over the history we have for it, the NADAC for VIVELLE-DOT 0.0375 MG PATCH has held within roughly two percent of its current level. It has been tracked across 105 weekly CMS publications since Nov 20, 2024.

What are the highest and lowest recorded NADAC prices for VIVELLE-DOT 0.0375 MG PATCH?

Since Nov 20, 2024, the NADAC for VIVELLE-DOT 0.0375 MG PATCH has ranged from a low of $18.3698 (Jan 21, 2026) to a high of $18.5252 (Dec 11, 2024), with a median of $18.3806 per EA.

Are there cheaper alternatives to VIVELLE-DOT 0.0375 MG PATCH?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ESTRADIOL 0.0375 MG PATCH(2/WK), is $8.1341 per EA — about 56% below VIVELLE-DOT 0.0375 MG PATCH.

Who manufactures VIVELLE-DOT 0.0375 MG PATCH?

VIVELLE-DOT 0.0375 MG PATCH (NDC 66758014683) is labeled by Sandoz Inc., and CMS classifies it as a brand product.